Internal Medicine, Nephrology · Naples, FL
NPI
1740422187
Since 2009
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
878 109th Ave N
Naples, FL, 34108
Phone (239) 513-1002
Groups this clinician bills Medicare through
Medicare paid, 2024
$326K
3,398 services
Medicare patients, 2024
888
Average age 77
Drug cost, 2024
$2.0M
3,638 prescriptions
Company payments, 2025
$62K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nijal Sheth was code 99232 (hospital e&m - subsequent), 1,286 times for 403 patients. In total Nijal Sheth billed 3,398 services in 27 codes, and Medicare paid $326K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-11-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,286 | 403 | $63.10 | $81K |
| 99214 Office E&M - Established | Office | 555 | 351 | $79.32 | $44K |
| 90960 ESRD Related Services (not dialysis) | Office | 289 | 54 | $266.75 | $77K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 283 | 224 | $13.11 | $3,711 |
| 99222 Hospital E&M - Initial | Facility | 148 | 140 | $103.92 | $15K |
| 99233 Hospital E&M - Subsequent | Facility | 123 | 87 | $93.76 | $12K |
| 90935 Hemodialysis | Facility | 111 | 57 | $55.93 | $6,208 |
| 99215 Office E&M - Established | Office | 105 | 90 | $112.25 | $12K |
| 99223 Hospital E&M - Initial | Facility | 103 | 102 | $135.91 | $14K |
| 90966 ESRD Related Services (not dialysis) | Office | 98 | 18 | $216.45 | $21K |
| 99204 Office E&M - New | Office | 91 | 91 | $124.99 | $11K |
| 90961 ESRD Related Services (not dialysis) | Office | 45 | 32 | $226.35 | $10K |
| 99205 Office E&M - New | Office | 33 | 33 | $167.07 | $5,513 |
| 99291 Critical Care E&M | Facility | 21 | 12 | $172.38 | $3,620 |
| 99427 Chronic, Principal, and Transitional Care Management | Office | 16 | 13 | $35.07 | $561 |
By year: 2022 $421K for 4,245 services; 2023 $349K for 3,349 services; 2024 $326K for 3,398 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nijal Sheth prescribed most often to Medicare patients was Calcitriol, with 338 prescriptions and refills. In total Nijal Sheth wrote 3,638 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcitriol Generic | 338 | 967 | 129 | $7,298 |
| Farxiga Dapagliflozin Propanediol | 333 | 703 | 86 | $390K |
| Losartan Potassium Generic | 289 | 837 | 100 | $2,802 |
| Jardiance Empagliflozin | 282 | 640 | 97 | $370K |
| Torsemide Generic | 222 | 638 | 102 | $4,896 |
| Amlodipine Besylate Generic | 158 | 446 | 59 | $1,088 |
| Allopurinol Generic | 130 | 353 | 45 | $1,279 |
| Hydralazine Hcl Generic | 104 | 271 | 42 | $1,788 |
| Furosemide Generic | 100 | 275 | 42 | $428 |
| Kerendia Finerenone | 93 | 194 | 25 | $124K |
| Metolazone Generic | 71 | 165 | 34 | $1,326 |
| Nifedipine Er Nifedipine | 62 | 177 | 32 | $1,643 |
| Potassium Chloride Generic | 61 | 155 | 23 | $2,035 |
| Veltassa Patiromer Calcium Sorbitex | 60 | 96 | 19 | $97K |
| Rayaldee Calcifediol | 56 | 58 | Under 11 | $75K |
Brand drugs: 1,099 claims; generic drugs: 2,539 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nijal Sheth $62K ($62K in general payments such as food, travel and fees) from 20 companies. The largest payer was Lilly USA, LLC with $31K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 43 | $31K |
| Akebia Therapeutics Inc AKBA | 59 | $21K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $9,000 |
| Calliditas Therapeutics US Inc. | 5 | $159 |
| Amgen Inc. AMGN | 6 | $157 |
| Travere Therapeutics, Inc. TVTX | 7 | $149 |
| OPKO Pharmaceuticals, LLC | 5 | $125 |
| Vantive US Healthcare LLC | 2 | $75.73 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $69.27 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $67.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.